Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
0.751
+0.007 (0.90%)
Nov 6, 2024, 4:00 PM EST - Market closed
Equillium Employees
Equillium had 44 employees as of December 31, 2023. The number of employees increased by 8 or 22.22% compared to the previous year.
Employees
44
Change (1Y)
8
Growth (1Y)
22.22%
Revenue / Employee
$968,705
Profits / Employee
-$189,045
Market Cap
26.62M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Concord Medical Services Holdings | 727 |
Pluri | 118 |
Tonix Pharmaceuticals Holding | 103 |
Enlivex Therapeutics | 71 |
Athira Pharma | 67 |
OneMedNet | 20 |
Tempest Therapeutics | 17 |
BriaCell Therapeutics | 16 |
EQ News
- 6 days ago - Equillium Maintains Rights to Itolizumab Following Ono Partnership - Business Wire
- 4 weeks ago - Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer - Business Wire
- 2 months ago - Equillium to Present at the Stifel Virtual Inflammation & Immunology Summit - Business Wire
- 2 months ago - Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - Equillium to Present at the Wells Fargo Healthcare Conference and the H.C. Wainwright 26th Annual Global Investor Conference - Business Wire
- 3 months ago - Equillium Reports Second Quarter 2024 Financial Results and Provides Recent Corporate and Clinical Highlights - Business Wire
- 3 months ago - Equillium Announces Positive Interim Analysis from Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease - Business Wire
- 3 months ago - Equillium Announces Second Quarter 2024 Estimated Cash and Investments Balance - Business Wire